相关实验视频
Updated: Jul 19, 2025

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
80.8K
一个年轻的西非人的结核相关拉斯穆森动脉瘤自发解决:一个案例报告
Kwasi Adjepong Twum1, Yaa Achiaa Afreh1, Adu Tutu Amankwa1,2
1Komfo Anokye Teaching Hospital (KATH). P.O. Box 1934, Kumasi, Ghana.
Radiology case reports
|August 18, 2023
概括
拉斯穆森动脉瘤是结核病中血液失血的罕见原因,可以保守地解决. 本案例研究表明,化学疗法具有成功的保守管理,在低资源环境中提供了可行的选择.
科学领域:
- 肺部医学 肺部医学
- 血管医学 血管医学
- 传染性疾病 传染性疾病
背景情况:
- 拉斯穆森动脉瘤 (RA) 是肺结核的一种罕见并发症,表现为血栓塞.
- 传统的治疗方法包括手术或内血管卷曲,但已注意到自发解脱.
研究的目的:
- 介绍一个患有肺结核的患者巨型左拉斯穆森动脉瘤的病例.
- 评估使用抗结核化疗进行保守管理的疗效.
主要方法:
- 一名44岁的患有血栓塞并被诊断为肺结核的患者接受了胸部CT,揭示了巨大的左侧RA.
- 患者接受了保守的抗结核化疗治疗.
主要成果:
- 在18个月的随访后,观察到巨型拉斯穆森动脉瘤的完全放射性解脱.
- 患者的血和其他症状通过保守治疗得到解决.
结论:
- 拉斯穆森动脉瘤的保守管理是一种可行的和有效的替代方案,特别是在资源有限的环境中.
- 抗结核化疗可以导致RA在血液动力学稳定患者的完整放射性解脱.
相关概念视频
Pulmonary Tuberculosis II
262
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
262
Pulmonary Tuberculosis IV
162
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
162
Pulmonary Tuberculosis I
266
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
266
Pulmonary Tuberculosis V
201
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
201
Pulmonary Tuberculosis III
363
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
363
Pneumothorax-II
196
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
196

